"Efficacy of Neural Prolotherapy for Treatment of Anserine Bursitis NPCAB"

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

October 30, 2019

Study Completion Date

October 30, 2019

Conditions
Anserine Bursitis
Interventions
DRUG

isotonic dextrose 5% in water (D5W) solution

Neurol prolotherapy (NP) is the subcutaneous perineural injection of isotonic dextrose 5% in water (D5W) solution.

DRUG

corticosteroid with local anaesthetics (40 mg of triamcinolone acetonide (40 mg/ml) with 1.5 ml mepivacaine HCl 3% )

Corticosteroid with local anaesthetics (40 mg of triamcinolone acetonide (40 mg/ml) with 1.5 ml mepivacaine HCl 3% ) (local anesthetic). They were given as a single local soft tissue injection at the point of maximal tenderness on the lower medial aspect of the knee region.

Trial Locations (1)

21131

Faculty of Medicine, Alexandria University, Alexandria

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT04509440 - "Efficacy of Neural Prolotherapy for Treatment of Anserine Bursitis NPCAB" | Biotech Hunter | Biotech Hunter